Replies to post #103393 on Ayala Pharmaceuticals Inc (fka ADXS)

[hdwrsft]

Still in clinical trials I believe....found this info at one vet listed under "clinical trials":


ARATANA AND SAGE

We’re conducting a clinical study for dogs with osteosarcoma who have undergone amputation and chemotherapy. There are eligibility requirements for your dog to participate in the study for the conditionally licensed Canine Osteosarcoma Vaccine, Live Listeria Vector and your veterinarian will review your dog’s medical history, perform a physical exam, take thoracic radiographs, and submit routine blood and urine tests. If you would like to learn more, please contact SAGE Centers at [e-mail] for more information.

[Bourbon_on_my_cornflakes]

Not True: $60 million dollar market cap for a company that has never achieved anything but washing away a $100 million down the toilet is ridiculous.

It was over $200m down the toilet with no deals or results.

Anybody heard from our savior the veterinarian lately?

We ought to replace all the management with veterinarians, as ADXS stock is a true dog.



Besides, the pet company, Aratana, was the only one to get a product to market.